Bicyclol(SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibiting HBV and HCV replication. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol […]
More Information Supplier Page
Bicyclol(SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibiting HBV and HCV replication. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol […]
More Information Supplier Page 
Farampator (CX-691;Org24448) is a positive modulator of AMPA receptor.
More Information Supplier Page
Farampator (CX-691;Org24448) is a positive modulator of AMPA receptor.
More Information Supplier Page Farampator (CX-691;Org24448) is a positive modulator of AMPA receptor.
More Information Supplier Page Farampator (CX-691;Org24448) is a positive modulator of AMPA receptor.
More Information Supplier Page 
NQ301, an antithrombotic agent, inhibits collagen-challenged rabbit platelet aggregation (IC50: 10 mg/mL).
More Information Supplier Page
NQ301, an antithrombotic agent, inhibits collagen-challenged rabbit platelet aggregation (IC50: 10 mg/mL).
More Information Supplier Page Farampator (CX-691;Org24448) is a positive modulator of AMPA receptor.
More Information Supplier Page 
